Singapore: December NODX moves past expectations
Date
1/17/2022 3:20:05 AM
(MENAFN- ING)
December NODX beat expectations but early 2022 could be different
Share
Author
Nicholas Mapa
Newsletter
Stay up to date with all of ING's latest economic and financial analysis.
Subscribe to THINK
| 18.4% | December NODX YoY growth
|
| Higher |
December NODX up 18.4%
Singapore's non-oil domestic exports (NODX) for December rose 18.4% (forecast at 12.9%). On a month-on-month basis, NODX gained 3.7% compared to a 0.8% expectation. The better-than-expected performance for NODX was tied to the 19.9% growth of non-electronics products after pharmaceuticals grew by an outsized 72.3% while petrochemical exports rose 28.4%. Electronics exports managed to expand 13.6% for December. The robust performance of NODX likely helped lift Singapore's 4Q 2021 GDP.
Singapore non-oil domestic exports (NODX)
Department of Statistics Singapore
Possible moderation in early 2022?
NODX will likely see some moderation in early 2022. The December NODX report indicated a slowdown in shipments to China and Taiwan while exports to Korea and the United States contracted by 16.4% and 25.6%, respectively. The contraction in shipments to Korea and the US coincided with the slowdown in electronics shipments for the month. Should these trends persist into 2022, possibly due to the surge in Covid-19 cases across the globe, NODX growth could moderate to start the year.
MENAFN17012022000222011065ID1103548957
*Content Disclaimer:
This publication has been prepared by ING solely for information purposes irrespective of a particular user's means, financial situation or investment objectives. The information does not constitute investment recommendation, and nor is it investment, legal or tax advice or an offer or solicitation to purchase or sell any financial instrument. Read more here: https://think.ing.com/about/disclaimer/
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.